These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7007281)

  • 41. [Non-steroid inflammatory drugs in the prevention of myocardial infarction].
    Basista M; Kostka-Trabka E
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1645-8. PubMed ID: 6382207
    [No Abstract]   [Full Text] [Related]  

  • 42. [5-aminosalicylic acid and thrombocyte function].
    Schölmerich J
    Dtsch Med Wochenschr; 1995 May; 120(20):742. PubMed ID: 7758415
    [No Abstract]   [Full Text] [Related]  

  • 43. [Secondary prevention of myocardial infarct. Drug therapy].
    Widimský J
    Vnitr Lek; 1982 Mar; 28(3):248-56. PubMed ID: 6126041
    [No Abstract]   [Full Text] [Related]  

  • 44. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
    Olson J; Huntington J
    J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anticoagulation therapy in myocardial infarction (author's transl)].
    Bucher HJ
    Schweiz Rundsch Med Prax; 1975 Apr; 64(14):425-32. PubMed ID: 765994
    [No Abstract]   [Full Text] [Related]  

  • 46. [Anticoagulants, thrombolytics and platelet aggregation inhibitors in the complex therapy of thrombosis of the central retinal vein and its branches].
    Krasnikov PG; Permiakova VV
    Oftalmol Zh; 1985; (5):289-93. PubMed ID: 4069516
    [No Abstract]   [Full Text] [Related]  

  • 47. [Secondary prevention following myocardial infarction].
    Kan G; Jaarsma W; Visser CA; Manger Cats V; Lie KI
    Ned Tijdschr Geneeskd; 1983 Feb; 127(6):257-61. PubMed ID: 6131385
    [No Abstract]   [Full Text] [Related]  

  • 48. Aspirin and its rivals. As your options increase, your choices get harder.
    Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
    [No Abstract]   [Full Text] [Related]  

  • 49. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin prevents strokes in middle-aged and older women, heart attacks in older women.
    Mayo Clin Womens Healthsource; 2005 Oct; 9(10):3. PubMed ID: 16224352
    [No Abstract]   [Full Text] [Related]  

  • 51. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis?
    Shah PK
    Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975
    [No Abstract]   [Full Text] [Related]  

  • 52. [New agents and challenges in the antithrombotic management of arterial diseases].
    Udvardy M; Rák K
    Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [What is safe in antithrombotic therapy after acute myocardial infarct?].
    Kirchhof B; van de Loo J
    Internist (Berl); 1982 Dec; 23(12):686-91. PubMed ID: 6819247
    [No Abstract]   [Full Text] [Related]  

  • 54. Evolving management of ST-segment elevation myocardial infarction: update on recent data.
    Cannon CP
    Am J Cardiol; 2006 Dec; 98(12A):10Q-21Q. PubMed ID: 17169625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract]   [Full Text] [Related]  

  • 56. Current status of antithrombotic agents in acute myocardial infarction.
    Khalilullah M; Sathyamurthy I
    J Assoc Physicians India; 1981 May; 29(5):351-7. PubMed ID: 7028713
    [No Abstract]   [Full Text] [Related]  

  • 57. [Anticoagulants and fibrinolytics in myocardial infarct].
    Messini M
    Clin Ter; 1967 Aug; 42(4):299-314. PubMed ID: 5608821
    [No Abstract]   [Full Text] [Related]  

  • 58. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Secondary prevention of myocardial infarct. Evaluation of a 2-year trial comparing acetylsalicylic acid to oral anticoagulants].
    Rev Prat; 1978 Jan; 28(1):43-56. PubMed ID: 635389
    [No Abstract]   [Full Text] [Related]  

  • 60. [Medical therapy of early post-infarct angina].
    Folli G; Guerrera G; Melina D; Capaldi L
    Minerva Cardioangiol; 1987 Dec; 35(12):673-82. PubMed ID: 3330772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.